头孢克洛(cefaclor),又名头孢氯氨苄,是结构与头孢氨苄相类似的第二代头孢菌类,该品首先由美国Eli Lilly(礼莱)公司创制,于1985年上市,由于其良好的疗效,故该品一面市就受到了医患双方的青睐,近年来,各生产厂家产销竞争渐超激烈,但因其市场潜力巨大,前景仍十分乐观。 自1985年头孢克洛上市以来,经过10余年的发展,其生产技 Cefaclor, also known as cephalexin, is a second-generation cephalosporin with a structure similar to cephalexin. The product was first created by Eli Lilly of the United States and was marketed in 1985 due to its good quality. Because of its therapeutic effect, the product was favored by both doctors and patients on one side of the market. In recent years, the competition between production and sales of various manufacturers has become increasingly fierce, but due to its huge market potential, the outlook is still very optimistic. Since the listing of cefaclor in 1985, after more than 10 years of development, its production technology